4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001053369-17-000004
$ELTPCIK 0001053369operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:41 PM ET
Size
5.0 KB
Accession
0001053369-17-000004
Insider Transaction Report
Form 4
Ward Carter Julian
Chief Financial Officer
Transactions
- Award
Common Stock
2017-02-23$0.23/sh+133,019$29,996→ 1,885,304 total
Holdings
- 1,355,014(indirect: By IRA)
Common Stock
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:41 PM ET
- Size
- 5.0 KB